Disclosed buying, with the evidence.
A buying pattern needs at least $100,000 on one buying day, at least 3× the median of five or more earlier comparable imported buying days, and at least two supporting checks. Comparisons use the same issuer, owner group, reported security and ownership account.
Supporting checks: CEO/CFO participation, multiple independent insider groups, repeated buying, or at least a 10% increase in comparable direct holdings. Recent activity covers 30 UTC trade-date days; earlier samples cover up to two years of imported evidence. History may be incomplete.
“Before earnings” also requires a fresh calendar observation and independently confirmed future release within 30 days. A provider date alone is not confirmed. Filing date, import time and assessment time stay separate. Same-day order is not inferred from before-open/after-close buckets.
These are experimental screening rules. They do not measure company quality, investment safety or the chance of profit. Full rules ↗
Bluerock Private Real Estate Fund
Reported buying activity, not a forecast. Not investment advice.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 4 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 13 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
PROTHENA CORP PUBLIC LTD CO
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 1 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 8 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Bluerock Private Real Estate Fund
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 3 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 13 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Xenon Pharmaceuticals Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: Chief Financial Officer
Two independent insider groups bought: 2 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Bluerock Private Real Estate Fund
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 2 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 13 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Hyperscale Data, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 10 earlier comparable imported buying days; at least five required.
CEO or CFO participated: Executive Chairman
Two independent insider groups bought: 2 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 10 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Earlier comparable buying-day median: $20.55K. Inspect the imported filing history ↗.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Xenon Pharmaceuticals Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: PRESIDENT & CEO
Two independent insider groups bought: 2 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Bluerock Private Real Estate Fund
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 1 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 13 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
PROTHENA CORP PUBLIC LTD CO
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 8 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
PROTHENA CORP PUBLIC LTD CO
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 1 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 8 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
ADARx Pharmaceuticals, Inc.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 5 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Bluerock Private Real Estate Fund
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 13 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Science Applications International Corp
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
Bluerock Private Real Estate Fund
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 1 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 3 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 3 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
PROTHENA CORP PUBLIC LTD CO
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 8 earlier comparable imported buying days; at least five required.
CEO or CFO participated: No CEO/CFO title in this purchase's reporting owners.
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 8 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Earlier comparable buying-day median: $452.36K. Inspect the imported filing history ↗.
Rule unusual-buying-1.0. Calculation and exclusions ↗
TriplePoint Venture Growth BDC Corp.
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: Chief Executive Officer
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
INTERNATIONAL TOWER HILL MINES LTD
At least $100,000 purchased: Same-account buying rows on this trade date are combined once.
At least 3× earlier imported purchase size: Median of 0 earlier comparable imported buying days; at least five required.
CEO or CFO participated: Chief Executive Officer
Two independent insider groups bought: 1 independent economic owner group(s) in the last 30 trade-date days.
The same group bought on multiple dates: 1 buying date(s) in the last 30 trade-date days.
Direct reported holdings increased at least 10%: Same-security direct holdings only; new or unclear positions have no comparable percentage baseline.
Reported before confirmed upcoming earnings: Earnings date is not independently verified.
Rule unusual-buying-1.0. Calculation and exclusions ↗
269 companies assessed; 0 have limited or failed assessment coverage. Large histories are left unassessed rather than truncated. Results expire if their assessment is older than 30 hours or the trade leaves the 30-day window.
Latest assessment: Oct 16, 2026, 04:56 AM UTC. Latest successful calendar retrieval: Oct 16, 2026, 04:15 AM UTC. Page rendering does not refresh source dates.
